Associate Professor of Surgery
Mayo Clinic
Chair of Vascular and Endovascular Surgery
Mayo Clinic
Rochester, Minnesota
Presenter
SESSION 33: PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM (FOR IMPORTANT RELATED TALKS SEE SESSION 33 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHSYMPOSIUM.ORG)
Presenter
SESSION 48: PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAS AND TAAAS; AND RELATED TOPICS
Presenter
SESSION 88: NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) GRAFT INFECTIONS
SESSION 33: PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM (FOR IMPORTANT RELATED TALKS SEE SESSION 33 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHSYMPOSIUM.ORG)
When Do Type II Endoleaks Cause Type I Endoleaks After Standard EVAR: How To Best Diagnose And Treat Them: Does One Need Proximal Aortic Control If Treatment Is Open Conversion
9:53 AM - 9:58 AM
Presenter
SESSION 48: PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAS AND TAAAS; AND RELATED TOPICS
Aneurysm Rupture During The Interval Of Staged Endovascular TAAA Repairs: How Frequent Is It And What Can Be Done To Prevent It: Optimal Delay For Stage 2
9:03 AM - 9:08 AM
Presenter
SESSION 88: NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) GRAFT INFECTIONS
The Real Truth About Use Of Cryopreserved Conduits (CryoGraft-Artivion) To Treat Infected Aortic/Arterial Reconstructions: From A Large Single Center Experience: There Are Advantages And Limitations
8:56 AM - 9:01 AM